How a Dark Horse Candidate is Upending the Sequencing Market

At the recent Advances in Genome Biology and Technology (AGBT) conference, Roche unveiled its SBX (Sequencing by Expansion) technology, developed by Stratos Genomics, a Seattle-based company Roche acquired in 2020. First teased in a pre-AGBT webinar, SBX could significantly impact the DNA sequencing market. Biotech investor Joe Horsman of Madrona Venture Group explores the technology’s unexpected origins, how it works, and its potential.